Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.

Mota, I; Umekita, L F.

Immunol Lett ; 21(3): 223-5, 1989 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-2504665

2.

Role of the antibody Fc in the immune clearance of Trypanosoma cruzi.

Umekita, L F; Takehara, H A; Mota, I.

Immunol Lett ; 17(1): 85-9, 1988 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-3127336

3.

Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.

Umekita, L F; Ramos, D P; Barbaro, K C; Mota, I.

Immunol Lett ; 70(2): 73-6, 1999 Nov 01.

Artículo en Inglés | MEDLINE | ID: mdl-10569694

4.

Changes of anti-Trypanosoma cruzi antibodies after gamma-irradiation of mice in the chronic phase of the infection.

Umekita, L F; Leite, R A; Barbaro, K C; Mota, I.

Acta Trop ; 75(2): 211-7, 2000 Mar 25.

Artículo en Inglés | MEDLINE | ID: mdl-10708661

5.

Role of the mononuclear phagocytic system in the immune and nonspecific clearance of Trypanosoma cruzi bloodstream trypomastigotes.

Umekita, L F; Mota, I.

Braz J Med Biol Res ; 22(12): 1489-95, 1989.

Artículo en Inglés | MEDLINE | ID: mdl-2518161

6.

How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?

Umekita, L F; Mota, I.

Braz J Med Biol Res ; 33(3): 253-8, 2000 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-10719375

7.

Role of platelets in the in vivo removal of T. cruzi from circulation.

Umekita, L F; Mota, I.

Braz J Med Biol Res ; 23(6-7): 593-6, 1990.

Artículo en Inglés | MEDLINE | ID: mdl-2101079

8.

Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.

Umekita, L F; Piazza, R M; Mota, I.

Braz J Med Biol Res ; 27(10): 2391-9, 1994 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-7640629

9.

Clearance-inducing antibodies are responsible for protection against the acute phase of Trypanosoma cruzi infection in mice.

Umekita, L F; Ramos, D P; Mota, I.

Braz J Med Biol Res ; 30(10): 1191-7, 1997 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-9496437

10.

Specificity and role of anti-Trypanosoma cruzi clearance antibodies.

Umekita, L F; Barbaro, K C; Mota, I.

Braz J Med Biol Res ; 29(1): 25-31, 1996 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8731328

11.

One fate of epimastigote forms of Trypanosoma cruzi injected in mice. An ultrastructural study.

Umekita, L F; Carneiro, S M; Mota, I.

J Parasitol ; 84(6): 1190-5, 1998 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9920312

12.

One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study.

Umekita, L F; Carneiro, S M; Sesso, A; Mota, I.

J Parasitol ; 85(5): 867-72, 1999 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-10577722

13.

Alterations of the microcirculatory network during the clearance of epimastigote forms of Trypanosoma cruzi: an intravital microscopic study.

Umekita, L F; Lopes-Ferreira, M; Piazza, R M; Umezawa, E S; Nascimento, M S; Farsky, S H; Mota, I.

J Parasitol ; 87(1): 114-7, 2001 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11227874

14.

[Measles: optimum age and number of doses recommended for vaccination in Brazil]. / Sarampo: idade ótima e número de doses recomendadas para a vacinação no Brasil.

Soerensen, B; Takeda, A K; Nakandakare, I K; Curi, L de C; Umekita, L F; Zuccas, W A; Guidoni, R; Magalhães, E; Britto, S S; Feijó, E I.

Rev Inst Med Trop Sao Paulo ; 27(2): 55-65, 1985.

Artículo en Portugués | MEDLINE | ID: mdl-4089457

15.

In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.

Umekita, L F; Mota, I.

Parasite Immunol ; 11(5): 561-6, 1989 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-2531362

16.

How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?

Umekita, L. F; Mota, I.

Braz. j. med. biol. res ; 33(3): 253-8, Mar. 2000.

Artículo en Inglés | LILACS | ID: lil-255044

17.

Clearance-inducing antibodies are responsible for protection against the acute phase of Trypanosoma cruzi infection in mice

Umekita, L. F; Ramos, D. P; Mota, I.

Braz. j. med. biol. res ; 30(10): 1191-7, Oct. 1997. tab, graf

Artículo en Inglés | LILACS | ID: lil-201537

18.

Role of platelets in the in vivo removal of T. cruzi from circulation

Umekita, L. F; Mota, I.

Braz. j. med. biol. res ; 23(6/7): 593-6, 1990. ilus

Artículo en Inglés | LILACS | ID: lil-92210

19.

Role of the mononuclear phagocytic system in the immune and nonspecific clearance of Trypanosoma cruzi bloodstream trypomastigotes

Umekita, L. F; Mota, I.

Braz. j. med. biol. res ; 22(12): 1489-95, Dec. 1989. ilus

Artículo en Inglés | LILACS | ID: lil-83154

20.

Specificity and role of anti-Trypanosoma cruzi clearance antibodies

Umekita, L. F; Barbaro, K. C; Mota, I.

Braz. j. med. biol. res ; 29(1): 25-31, Jan. 1996. graf, tab

Artículo en Inglés | LILACS | ID: lil-161649

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.

Role of the antibody Fc in the immune clearance of Trypanosoma cruzi.

Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.

Changes of anti-Trypanosoma cruzi antibodies after gamma-irradiation of mice in the chronic phase of the infection.

Role of the mononuclear phagocytic system in the immune and nonspecific clearance of Trypanosoma cruzi bloodstream trypomastigotes.

How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?

Role of platelets in the in vivo removal of T. cruzi from circulation.

Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.

Clearance-inducing antibodies are responsible for protection against the acute phase of Trypanosoma cruzi infection in mice.

Specificity and role of anti-Trypanosoma cruzi clearance antibodies.

One fate of epimastigote forms of Trypanosoma cruzi injected in mice. An ultrastructural study.

One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study.

Alterations of the microcirculatory network during the clearance of epimastigote forms of Trypanosoma cruzi: an intravital microscopic study.

[Measles: optimum age and number of doses recommended for vaccination in Brazil]. / Sarampo: idade ótima e número de doses recomendadas para a vacinação no Brasil.

In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.

How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi?

Clearance-inducing antibodies are responsible for protection against the acute phase of Trypanosoma cruzi infection in mice

Role of platelets in the in vivo removal of T. cruzi from circulation

Role of the mononuclear phagocytic system in the immune and nonspecific clearance of Trypanosoma cruzi bloodstream trypomastigotes

Specificity and role of anti-Trypanosoma cruzi clearance antibodies